Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
May 2007
2007:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Celebrity genomes alarm researchers
Genome researchers are questioning the plans of some of their number to stage high-profile releases of their very own genome sequences.
Nature (24 May 2007)
| Full Text |
Help flies in for human genome
Analysis of data from the ENCODE project, which aims to catalogue all the functional parts of the human genome, will be facilitated by the recently launched modENCODE project that targets C. elegans and D. melanogaster genomes.
Nature (24 May 2007)
| Full Text |
Japan centres aim to put science in premier league
The creation of five new top research centers are the latest in a long line of efforts to make Japanese research more flexible and international in outlook.
Nature (24 May 2007)
| Full Text |
NIH presents the mind of a child
A US National Institutes of Health (NIH) study into brain development during childhood is creating a database as a benchmark against which researchers on other studies can compare their data.
Nature (24 May 2007)
| Full Text |
Modellers seek reason for low retraction rates
A mathematical model to estimate the number of flawed scientific papers that go unretracted raises as many questions as it answers.
Nature (17 May 2007)
| Full Text |
India struggles to find director for top research agency
India's largest research agency has been without a permanent director for almost five months, prompting some observers to claim that science isn't high on the government's agenda.
Nature (17 May 2007)
| Full Text |
Applicants challenge male order at Howard Hughes
The Howard Hughes Medical Institute's requirement that applicants must have run a lab for between four and ten years can make it hard for women with children to succeed.
Nature (17 May 2007)
| Full Text |
Time runs short for HapMap
Recently developed tools for fast DNA sequencing could soon make HapMap, the database of single nucleotide polymorphisms, obsolete.
Nature (17 May 2007)
| Full Text |
Seven-year grant offers immune tolerance a boost
The US National Institutes of Health has awarded a $220 million, 7-year grant to the NIH's Immune Tolerance Network to study autoimmune disorders and basic immunology.
Nature (10 May 2007)
| Full Text |
High-profile departure ends genome institute's charmed run
Claire Fraser-Liggett has left The Institute for Genomic Research (TIGR) to oversee a new institute of genome sciences at the University of Maryland, Baltimore.
Nature Medicine (May 2007)
| Full Text |
Epilepsy controlled by low-carb diet's effect on brain channels
Harvard University researchers have found that a diet low in carbohydrates may control epileptic episodes by enhancing the function of electrical switches in an area of the brain that controls seizures.
Nature Medicine (May 2007)
| Full Text |
Criticism swells against AIDS program's abstinence policy
The US Institute of Medicine joins scientists and activists in requesting that abstinence-until-marriage requirements be removed from the overseas AIDS assistance program President's Emergency Plan for AIDS Relief (PEPAR).
Nature Medicine (May 2007)
| Full Text |
Scientists, NIH in conflict over precious HIV samples
AIDS researchers allege that the US National Institutes of Health is refusing to fund grants unless researchers collaborate with the NIH's Center for HIV-AIDS Vaccine Immunology.
Nature Medicine (May 2007)
| Full Text |
US tosses out patents on three Wisconsin stem cell lines
The US government in March moved to revoke three key patents on human embryonic stem cell lines developed by James Thomson, a University of Wisconsin researcher widely considered to be the first to isolate and culture such cells.
Nature Medicine (May 2007)
| Full Text |
Critics pan timid European response to TeGenero disaster
The European Medicines Evaluation Agency's (EMEA) proposals for improving the safety of first-in-human trials of novel biological agents are called weak and insufficient.
Nature Biotechnology (May 2007)
| Full Text |
Cimzia's setback paves way for other TNF inhibitors in Crohn's disease
The slow progress of Cimzia (certolizumab pegol) in clinical trials clears the way for the debut of other TNF-α inhibitors.
Nature Biotechnology (May 2007)
| Full Text |
Despite glacial progress, US government signals support for personalized medicine
The US Department of Health and Human Services' report on personalized healthcare recommends including pharmacogenomics and other approaches that involve developing diagnostic and therapeutic products in tandem.
Nature Biotechnology (May 2007)
| Full Text |
Reform makes Italian research accountable
An independent evaluation agency will assess the quality of the research produced by Italian universities, with budgetary consequences for over-or under-performing institutes.
Nature (03 May 2007)
| Full Text |
Denmark launches big push for protein power
The Novo Nordisk Foundation has announced a US $110 million donation to fund a protein research center at the University of Copenhagen, Denmark.
Nature (03 May 2007)
| Full Text |
Rapid sequencer puts virus in the frame for deaths
New sequencing technology reduces the time needed to identify viral contamination of donor transplant organs.
Nature (03 May 2007)
| Full Text |
Patenting the obvious?
A preliminary decision by the US Patent and Trademark Office revokes three long-standing patents on stem cell technology, a victory for stem-cell researchers.
Nature (03 May 2007)
| Full Text |
News in brief
| Concern over teen suicides extends flu-drug probe
| Creationist museum to open in Kentucky
| Charity announces deal for cheap AIDS drugs
| Massachusetts proposes $1 billion for life sciences
| Medical Research Council emphasizes clinical work
| US judges rule against patenting the obvious
| Animal-rights activists lose one, win one
| Stem-cell institute agrees to more public consultation
| Tap your toes to transcription factors
| News in brief
| Invigorated immunotherapy
| Angels smile on biotech, fill post-seed gap
| EU binder project
| Recombinant polyclonals progress
| Eisai opts into antibodies
| US House backs bill to bar genetic discrimination
| European grants give starters a helping hand
| Living relative found for lonesome tortoise
News Features
Neuroscience: The molecular wake-up call
In 1957, Arvid Carlsson showed dopamine to be a neurotransmitter, but it took several years to convince the scientific community that the brain is not just an electrical machine.
Nature (24 May 2007)
| Full Text |
Scientific activism: Signing on
When you win a Nobel prize, you become much in demand, but how do laureates decide which worthy causes to lend their name to?
Nature (24 May 2007)
| Full Text |
Biomedical philanthropy: State of the donation
Wealthy philanthropists and private foundations are supporting biomedical research on a grand scale, but what do they get for their money?
Nature (17 May 2007)
| Full Text |
Biomedical philanthropy: The money tree
Donations from philanthropists and private foundations are increasingly finding their way into biomedical research, but who are some of the richest and most influential funders?
Nature (17 May 2007)
| Full Text |
Biomedical philanthropy: Love or money
Biomedical scientists want funding; private foundations want cures. Erika Check hears the joys and tensions that arise when the two hook up.
Nature (17 May 2007)
| Full Text |
Biomedical philanthropy: The giving machine
Flush with Microsoft's fortune, the Bill & Melinda Gates Foundation is the largest charitable foundation in the United States. Tadataka Yamada, executive director of its Global Health Program, tells Lucy Odling-Smee how the organization aims to save lives with its wealth.
Nature (17 May 2007)
| Full Text |
The good, the bad and the ugly
Imaging fluorescent molecules in live cells is revolutionizing cell biology — but a pretty image is not necessarily a good one, as many biologists are now learning.
Nature (10 May 2007)
| Full Text |
Bugs vs. Drugs
Up to 70% of Staphylococcus aureus infections seen in emergency rooms are resistant to methicillin, a derivative of penicillin.
Nature Medicine (May 2007)
| Full Text |
Antisense—down, but not out
Antisense RNA-based drugs may be headed for a renaissance with promising news about Isis Pharmaceuticals' new cholesterol-lowering drug.
Nature Biotechnology (May 2007)
| Full Text |
HIV: A tale of two centres
Two South African institutes intent on tackling HIV are suffering because of a lack of collaboration, despite the scale of the HIV crisis in South Africa and the overlap in the institutes' grants.
Nature (03 May 2007)
| Full Text |
|
